Unmodified official OCDS data retained by Tenderline for this procurement process.
Complete current OCDS release JSON
{
"id": "036011-2024",
"tag": [
"award",
"contract"
],
"bids": {
"statistics": [
{
"id": "1",
"value": 1,
"measure": "bids",
"relatedLot": "1"
}
]
},
"date": "2024-11-07T08:46:50Z",
"ocid": "ocds-h6vhtk-04b484",
"buyer": {
"id": "GB-FTS-81269",
"name": "NHS England"
},
"awards": [
{
"id": "036011-2024-1",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-21063",
"name": "Guy's and St Thomas' NHS Foundation Trust"
}
],
"relatedLots": [
"1"
]
}
],
"tender": {
"id": "ocds-h6vhtk-04b484",
"lots": [
{
"id": "1",
"status": "cancelled",
"options": {
"description": "There is an option to extend the contract for an additional 2 years."
},
"hasOptions": true,
"description": "DNA nucleotide excision repair (DNA) disorders include xeroderma pigmentosa (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD). Xeroderma Pigmentosa (XP) service was commissioned as a HSS in 2010, the service specification was updated in 2018 to include the CS and TTD. These are rare inherited multi-organ disorders and patients have specific, complex and specialist needs. Although the underlying diseases are not curable, there is potential to significantly improve health and quality of life through a comprehensive, expert patient focused service. Many individuals with CS/TTD require photoprotection, have reduced mobility or are on supplemental feeds. These circumstances can impact their ability to maintain optimal vitamin D levels. Therefore, regular vitamin D monitoring is important. are genetic conditions that are complex to diagnose and treat, and require input from: dermatology, dermatological surgery, paediatric neurology, adult neurology, ophthalmology, neuropsychology, clinical genetics, paediatric dentistry, psychology, dietetics, endocrinology, optometry, medical photography, audiology and palliative care. \nAn award has been made following direct award process A. \nThe service started on 1st April 2024 for a period of 3 years with an option to extend for a further 2 years.\nThe lifetime value of the contract is £7,186,475.00.",
"awardCriteria": {
"criteria": [
{
"name": "No realistic alternative provider",
"type": "cost",
"description": "100"
}
]
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKI"
}
]
}
],
"title": "DNA Repair Disorders Service",
"status": "complete",
"coveredBy": [
"GPA"
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "DNA nucleotide excision repair (DNA) disorders include xeroderma pigmentosa (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD). Xeroderma Pigmentosa (XP) service was commissioned as a HSS in 2010, the service specification was updated in 2018 to include the CS and TTD. These are rare inherited multi-organ disorders and patients have specific, complex and specialist needs. Although the underlying diseases are not curable, there is potential to significantly improve health and quality of life through a comprehensive, expert patient focused service. Many individuals with CS/TTD require photoprotection, have reduced mobility or are on supplemental feeds. \nThe conditions are complex to diagnose and treat, and require input from: dermatology, dermatological surgery, paediatric neurology, adult neurology, ophthalmology, neuropsychology, clinical genetics, paediatric dentistry, psychology, dietetics, endocrinology, optometry, medical photography, audiology and palliative care.",
"classification": {
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
},
"procurementMethod": "limited",
"mainProcurementCategory": "services",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.",
"procurementMethodRationaleClassifications": [
{
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"description": "The procurement falls outside the scope of application of the directive"
}
]
},
"parties": [
{
"id": "GB-FTS-81269",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UK",
"locality": "Leeds",
"countryName": "United Kingdom"
},
"details": {
"url": "https://www.england.nhs.uk//",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"legalName": "NHS England",
"noIdentifierRationale": "notOnAnyRegister"
},
"contactPoint": {
"name": "Anna Salt",
"email": "anna.salt@nhs.net"
}
},
{
"id": "GB-FTS-21063",
"name": "Guy's and St Thomas' NHS Foundation Trust",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "London",
"countryName": "United Kingdom"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Guy's and St Thomas' NHS Foundation Trust",
"noIdentifierRationale": "notOnAnyRegister"
}
},
{
"id": "GB-FTS-129349",
"name": "Arden & Gem CSU",
"roles": [
"reviewBody"
],
"address": {
"locality": "Leicester",
"postalCode": "LE1 6NB",
"countryName": "United Kingdom",
"streetAddress": "St John's House, East Street"
},
"identifier": {
"legalName": "Arden & Gem CSU"
}
}
],
"language": "en",
"contracts": [
{
"id": "036011-2024-1",
"value": {
"amount": 7186475,
"currency": "GBP"
},
"status": "active",
"awardID": "036011-2024-1",
"dateSigned": "2024-09-05T00:00:00+01:00"
}
],
"description": "This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.\nDecision makers: National Commissioning Group (NCG)\nTuesday 27th February 2024 AND Clinical Executive Group (CEG) \nTuesday 12th March 2024\nConflicts of Interest identified among NCG and CEG: None",
"initiationType": "tender"
}Complete JSON history (1 releases)
7 Nov 2024 · 036011-2024 · award, contract
{
"id": "036011-2024",
"tag": [
"award",
"contract"
],
"bids": {
"statistics": [
{
"id": "1",
"value": 1,
"measure": "bids",
"relatedLot": "1"
}
]
},
"date": "2024-11-07T08:46:50Z",
"ocid": "ocds-h6vhtk-04b484",
"buyer": {
"id": "GB-FTS-81269",
"name": "NHS England"
},
"awards": [
{
"id": "036011-2024-1",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-21063",
"name": "Guy's and St Thomas' NHS Foundation Trust"
}
],
"relatedLots": [
"1"
]
}
],
"tender": {
"id": "ocds-h6vhtk-04b484",
"lots": [
{
"id": "1",
"status": "cancelled",
"options": {
"description": "There is an option to extend the contract for an additional 2 years."
},
"hasOptions": true,
"description": "DNA nucleotide excision repair (DNA) disorders include xeroderma pigmentosa (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD). Xeroderma Pigmentosa (XP) service was commissioned as a HSS in 2010, the service specification was updated in 2018 to include the CS and TTD. These are rare inherited multi-organ disorders and patients have specific, complex and specialist needs. Although the underlying diseases are not curable, there is potential to significantly improve health and quality of life through a comprehensive, expert patient focused service. Many individuals with CS/TTD require photoprotection, have reduced mobility or are on supplemental feeds. These circumstances can impact their ability to maintain optimal vitamin D levels. Therefore, regular vitamin D monitoring is important. are genetic conditions that are complex to diagnose and treat, and require input from: dermatology, dermatological surgery, paediatric neurology, adult neurology, ophthalmology, neuropsychology, clinical genetics, paediatric dentistry, psychology, dietetics, endocrinology, optometry, medical photography, audiology and palliative care. \nAn award has been made following direct award process A. \nThe service started on 1st April 2024 for a period of 3 years with an option to extend for a further 2 years.\nThe lifetime value of the contract is £7,186,475.00.",
"awardCriteria": {
"criteria": [
{
"name": "No realistic alternative provider",
"type": "cost",
"description": "100"
}
]
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKI"
}
]
}
],
"title": "DNA Repair Disorders Service",
"status": "complete",
"coveredBy": [
"GPA"
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "DNA nucleotide excision repair (DNA) disorders include xeroderma pigmentosa (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD). Xeroderma Pigmentosa (XP) service was commissioned as a HSS in 2010, the service specification was updated in 2018 to include the CS and TTD. These are rare inherited multi-organ disorders and patients have specific, complex and specialist needs. Although the underlying diseases are not curable, there is potential to significantly improve health and quality of life through a comprehensive, expert patient focused service. Many individuals with CS/TTD require photoprotection, have reduced mobility or are on supplemental feeds. \nThe conditions are complex to diagnose and treat, and require input from: dermatology, dermatological surgery, paediatric neurology, adult neurology, ophthalmology, neuropsychology, clinical genetics, paediatric dentistry, psychology, dietetics, endocrinology, optometry, medical photography, audiology and palliative care.",
"classification": {
"id": "85000000",
"scheme": "CPV",
"description": "Health and social work services"
},
"procurementMethod": "limited",
"mainProcurementCategory": "services",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.",
"procurementMethodRationaleClassifications": [
{
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"description": "The procurement falls outside the scope of application of the directive"
}
]
},
"parties": [
{
"id": "GB-FTS-81269",
"name": "NHS England",
"roles": [
"buyer"
],
"address": {
"region": "UK",
"locality": "Leeds",
"countryName": "United Kingdom"
},
"details": {
"url": "https://www.england.nhs.uk//",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"legalName": "NHS England",
"noIdentifierRationale": "notOnAnyRegister"
},
"contactPoint": {
"name": "Anna Salt",
"email": "anna.salt@nhs.net"
}
},
{
"id": "GB-FTS-21063",
"name": "Guy's and St Thomas' NHS Foundation Trust",
"roles": [
"supplier"
],
"address": {
"region": "UKI",
"locality": "London",
"countryName": "United Kingdom"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Guy's and St Thomas' NHS Foundation Trust",
"noIdentifierRationale": "notOnAnyRegister"
}
},
{
"id": "GB-FTS-129349",
"name": "Arden & Gem CSU",
"roles": [
"reviewBody"
],
"address": {
"locality": "Leicester",
"postalCode": "LE1 6NB",
"countryName": "United Kingdom",
"streetAddress": "St John's House, East Street"
},
"identifier": {
"legalName": "Arden & Gem CSU"
}
}
],
"language": "en",
"contracts": [
{
"id": "036011-2024-1",
"value": {
"amount": 7186475,
"currency": "GBP"
},
"status": "active",
"awardID": "036011-2024-1",
"dateSigned": "2024-09-05T00:00:00+01:00"
}
],
"description": "This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.\nDecision makers: National Commissioning Group (NCG)\nTuesday 27th February 2024 AND Clinical Executive Group (CEG) \nTuesday 12th March 2024\nConflicts of Interest identified among NCG and CEG: None",
"initiationType": "tender"
}